Fig. 2

Study outcomes: GLP-1RAs were associated with an increased rate of pre-procedural GI symptoms, GLP-1RAs resulted in an expressive increase in RGC compared to the control, GLP-1RAs improved glycemic control, and subgroup with 100% diabetics and GLP-1RAs improved glycemic control with zero heterogeneity